The University of Queensland

Human Leukaemia Inhibitory Factor (hLIF): A Potential Anti-Atherosclerotic/Anti-Restenotic Agent (1998–2000)

Grant type:

NHMRC Project Grant

Researchers:

• 

  Associate Professor Barbara Rolfe

  Principal Research Fellow and GL
  

  Australian Institute for Bioengineering and Nanotechnology

Funded by:

National Health and Medical Research Council